Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan

ABSTRACT The latest guidelines include azithromycin as a preferred regimen for treating Mycobacterium avium complex (MAC) pulmonary disease. However, serially collected susceptibility data on clinical MAC isolates are limited, and no breakpoints have been determined. We investigated the minimum inhi...

Full description

Bibliographic Details
Main Authors: Yoshifumi Uwamino, Wataru Aoki, Rika Inose, Yuka Kamoshita, Kei Mikita, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita, Naoki Hasegawa
Format: Article
Language:English
Published: American Society for Microbiology 2024-06-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00218-24